Lynda Berne, Consultant, Commercial and Business Strategy
Lynda Berne is founder of BAL Pharma Consulting, LLC, a Princeton, NJ Management Consulting firm providing Commercial and Business Strategy and Valuation to Specialty Pharma and Biotech. The U.S. and European client base consists of companies in a range of therapeutic areas, including anti-bacterials, critical care, immunology, GI, nephrology, and pain. Lynda has over 18 years in senior and executive commercial roles in pharma, including 13 years at Bristol-Myers Squibb where she held the role of Vice President, Infectious Disease Marketing, managing a $600M business unit and providing leadership in the launch of Tequin (IV/oral gatifloxacin), which set a new prescription record for the quinolone class. Other senior commercial positions held include: Vice President, Managed Health Care Sales, Bristol-Myers Squibb, General Manager, Hospital/CV Portfolio, a $1B business unit, Abbott International, and Executive Director, Gastroenterology/Nephrology Marketing, a $200M business unit, Shire Pharmaceuticals. Lynda has a BS in Nursing from Indiana University, an MS in Nursing from DePaul University and an MBA from Northwestern University, Kellogg Graduate School of Management.